Özcengiz, E. Et Al. 2022. Two formulations of coronavirus disease-19 recombinant subunit vaccine candidate made up of S1 fragment protein P1, S2 fragment protein P2, and nucleocapsid protein elicit strong immunogenicity in mice. Immunity, Inflammation and Disease , vol.10, no.12 .

Özcengiz, E., Keser, D., Özcengiz, G., Çelik, G., Özkul, A., & İnçeh, F. N., (2022). Two formulations of coronavirus disease-19 recombinant subunit vaccine candidate made up of S1 fragment protein P1, S2 fragment protein P2, and nucleocapsid protein elicit strong immunogenicity in mice. Immunity, Inflammation and Disease , vol.10, no.12.

Özcengiz, Erkan Et Al. "Two formulations of coronavirus disease-19 recombinant subunit vaccine candidate made up of S1 fragment protein P1, S2 fragment protein P2, and nucleocapsid protein elicit strong immunogenicity in mice," Immunity, Inflammation and Disease , vol.10, no.12, 2022

Özcengiz, Erkan Et Al. "Two formulations of coronavirus disease-19 recombinant subunit vaccine candidate made up of S1 fragment protein P1, S2 fragment protein P2, and nucleocapsid protein elicit strong immunogenicity in mice." Immunity, Inflammation and Disease , vol.10, no.12, 2022

Özcengiz, E. Et Al. (2022) . "Two formulations of coronavirus disease-19 recombinant subunit vaccine candidate made up of S1 fragment protein P1, S2 fragment protein P2, and nucleocapsid protein elicit strong immunogenicity in mice." Immunity, Inflammation and Disease , vol.10, no.12.

@article{article, author={Erkan Özcengiz Et Al. }, title={Two formulations of coronavirus disease-19 recombinant subunit vaccine candidate made up of S1 fragment protein P1, S2 fragment protein P2, and nucleocapsid protein elicit strong immunogenicity in mice}, journal={Immunity, Inflammation and Disease}, year=2022}